<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02700269</url>
  </required_header>
  <id_info>
    <org_study_id>MRT15003.2</org_study_id>
    <secondary_id>5D43TW009348</secondary_id>
    <nct_id>NCT02700269</nct_id>
    <nct_alias>NCT02698774</nct_alias>
  </id_info>
  <brief_title>Vanderbilt-Zambia Innovations in Global Health Technologies</brief_title>
  <acronym>VZNIGHT</acronym>
  <official_title>Vanderbilt-Zambia Innovations in Global Health Technologies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Macha Research Trust, Zambia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>John E. Fogarty International Center (FIC)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Macha Research Trust, Zambia</source>
  <brief_summary>
    <textblock>
      Investigators will evaluate approaches using magnetic bead capture, isolation, and surface
      tension valve transfer of biomarkers to process capillary blood in order to improve the
      sensitivity of already approved Rapid Diagnostic Tests (RDTs) for detection of human malaria
      infection. Results will be compared to those obtained using unenhanced capillary blood
      specimens directly applied to approved malaria RDTs. Participants seeking care for possible
      malaria in Zambia will be recruited to enroll in the study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Actual">February 2019</completion_date>
  <primary_completion_date type="Actual">February 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Enhancement of malaria RDT to detect low levels of P falciparum parasites</measure>
    <time_frame>5 years</time_frame>
    <description>The expected outcome of this research project is to enhance the ability of standard malaria RDTs to detect low levels of Plasmodium falciparum malaria in human capillary blood.</description>
  </primary_outcome>
  <enrollment type="Actual">278</enrollment>
  <condition>Malaria Diagnosis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>mBEADS</intervention_name>
    <description>Evaluate approaches using magnetic bead capture, isolation, and surface tension valve transfer of biomarkers to improve the sensitivity of already approved malaria RDTs.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Those seeking care for suspected malaria in Zambia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals giving written informed consent for themselves

          -  Children under the age of 18 for whom a parent or guardian can give consent

          -  Individuals seeking care or treatment of suspected or possible malaria

          -  Individuals being screened as a contact of someone with recent malaria

          -  Other individuals willing to have their blood tested for malaria

        Exclusion Criteria:

          -  Anyone over 18 unwilling or unable to provide informed consent

          -  Anyone under 18 who does not have a parent or guardian to give consent

          -  Anyone between the age of 12 and 18 who does not give assent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Macha Research Trust</name>
      <address>
        <city>Choma</city>
        <country>Zambia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Zambia</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 25, 2016</study_first_submitted>
  <study_first_submitted_qc>March 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2016</study_first_posted>
  <last_update_submitted>February 18, 2020</last_update_submitted>
  <last_update_submitted_qc>February 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malaria</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

